Business
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025
VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor
About this update from Abcellera Biologics Inc.
[{"type":"text","content":" VANCOUVER, British Columbia--(BUSINESS WIRE)--\nAbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:\n\n\n\nTruist Securities BioPharma Symposium, November 6, 2025\n\n\n\nStifel Healthcare Conference, November 11-13, 2025\n\n\n\nJefferies Global Healthcare Conference, November 18-20, 2025\n\n\n\nPiper Sandler 37th Annual Healthcare Conference, December 2-4, 2025\n\n\n\nVisit AbCellera's Investor Relations website for additional information.\n\n\nAbout AbCellera Biologics Inc.\n\n\nAbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20251007123988/en/\n\nInquiries\nMedia: Tiffany Chiu; [email protected], +1(236)521-6774\nPartnering: Murray McCutcheon, Ph.D.; [email protected], +1(604)559-9005\nInvestor Relations: Peter Ahn; [email protected], +1(778)729-9116\n\n\nSource: AbCellera Biologics Inc.","length":3337,"tagName":"div"}]